Targeted local therapy in oligometastatic prostate cancer: a promising potential opportunity after failed primary treatment

Publisher： John Wiley & Sons Inc

E-ISSN： 1464-410x|116|2|170-172

ISSN： 1464-4096

Source： BJU INTERNATIONAL, Vol.116, Iss.2, 2015-08, pp. : 170-172

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

[11C]Choline PET/CT for Targeted Salvage Lymph Node Dissection in Patients with Biochemical Recurrence after Primary Curative Therapy for Prostate Cancer

By  

Urologia Internationalis, Vol. 81, Iss. 2, 2008-08 ,pp. : 191-197

Karger

Access to resources Recommend Favorite

Local treatment of high risk prostate cancer: Role of surgery and radiation therapy

By  

CANCER, Vol. 120, Iss. 11, 2014-06 ,pp. : 1608-1610

John Wiley & Sons Inc

Access to resources Recommend Favorite

Osteoclast-targeted therapy for metastatic prostate cancer

By Lee Richard J   Smith Matthew R  

Therapy, Vol. 5, Iss. 1, 2008-01 ,pp. : 63-72

Future Medicine

Access to resources Recommend Favorite

Rising Prostate-Specific Antigen after Primary Treatment of Prostate Cancer: Sequential Hormone Manipulation

By  

Urologia Internationalis, Vol. 79, Iss. 2, 2007-09 ,pp. : 95-104

Karger

Access to resources Recommend Favorite

Docetaxel, bevacizumab, and androgen deprivation therapy for biochemical disease recurrence after definitive local therapy for prostate cancer

By  

CANCER, Vol. 121, Iss. 15, 2015-08 ,pp. : 2603-2611

John Wiley & Sons Inc

Access to resources Recommend Favorite